Real World Evidence

Real World Evidence. Real Confidence. Real Results.

IQVIA Real World Solutions is the proven partner for real-world evidence that meets stakeholder needs with confidence, delivering real impact for clients, clinicians and patients.

Our capabilities are designed to answer a variety of research questions

Discover our solutions

Engagements
300+

Involving UK real world datasets between 2022-2025

studies using English Cancer Registry
114+

Around 70 studies focused on solid tumours, and 44 have focused on Haem-Oncology malignancies

Patients
+20M

IQVIA datasets and collaborations allow access to records of over 20 million patients in the UK

Reduction in study delivery timelines
Up to 50%

Use of health analytics platforms for speed, scalability, reproducibility and high-quality outputs for retrospective database analyses

Studies
In 20+ Therapy Areas

Between 2022 – 2025, UK database studies covered more than 20 therapy areas, including Oncology, Diabetes and Mental Health

Abstract, Articles and Reviews
100+

Utilising UK datasets listed in IQVIA RWS Bibliography

Scotland Cardiometabolic Impact Study (SCoMIS)​

Transforming Obesity Care for Scotland’s Most Deprived Communities

Working alongside the Universities of Glasgow, Dundee and Edinburgh, and Novo Nordisk, this landmark real-world study will explore how weight-loss medicines can be delivered effectively and fairly in everyday GP and pharmacy settings; helping millions live longer healthier lives - a UK Government-funded programme focused on improving outcomes for thousands of patients in Scotland’s most deprived communities.
Real World Evidence and Clinical Technology Solutions Bibliography
This database features the published work of IQVIA Real-World Solutions experts around the world. It contains articles, papers and books written, presentations delivered and posters made.
Meet the team
Caroline leads Real World Evidence across the UKI and the Nordics, bringing extensive experience in delivering impactful evidence generation programmes. With a background in statistics and over 20 years in healthcare research, she has led studies across clinical trials and real-world evidence, supporting clients to generate insights that improve patient care and decision‑making.
Timothy leads the Real World Primary Data Collection Studies business, providing strategic oversight and leadership of non-interventional research that collects data from primary sources. He has 16 years of experience across pharmaceutical research in both the private sector and the UK National Health Service, including over 11 years specialising in real-world evidence. Tim has overseen the conception and delivery of more than 100 RWE studies across multiple disease areas and methodologies, including protocol development, regulatory and ethical submissions, project management, scientific reporting, and publication planning.
Rachel leads Real World Database Studies across the UK&I, providing strategic oversight of database-driven evidence generation. With 15 years of experience within the pharmaceutical industry, she specialises in leveraging real-world data to generate insights that support clinical, commercial, and healthcare decision-making. Prior to joining IQVIA, Rachel led operations for large-scale database studies and real-world evidence programmes, driving operational excellence and project delivery. Her experience spans clinical trial management, real-world evidence research, and safety pharmacology.
Stephen is an Associate Principal in IQVIA’s UK Real World Evidence team, with over nine years of experience working with oncology registries and real world evidence. His work focuses on generating high-quality data and insights to support decision-making across the cancer pathway. Prior to joining IQVIA, Stephen worked at Public Health England’s National Cancer Registration and Analysis Service, where he managed the Systemic Anti-Cancer Therapy (SACT) dataset and supported Cancer Drugs Fund appraisals and national reporting initiatives.
Sarah is a Principal within the Real World Solutions team at IQVIA, with over 14 years of experience delivering real-world evidence studies for life sciences clients. She has led a broad range of epidemiological and comparative effectiveness studies across therapy areas including diabetes, cardiovascular disease, oncology, and rare diseases. Sarah has extensive experience working with UK data assets, including CPRD-HES and IQVIA’s proprietary IQVIA Medical Research Data (IMRD) and Longitudinal Patient Data (LPD) databases, and supports the delivery of projects for NHS and public-sector organisations. As a qualified pharmacist with an MSc in Economic Evaluation in Healthcare, she specialises in developing practical, client-focused evidence solutions.
Rory is a Principal within the Real World Solutions team based in London and a subject matter expert in Post Authorisation Safety Studies. He brings 15 years of pharmaceutical industry experience, leading complex, data-driven, multi-country studies involving multidisciplinary teams. Rory has extensive expertise in global studies using real-world secondary data, with a particular focus on the UK evidence landscape. His work has included Post Authorisation Safety Studies supporting EMA and FDA requirements, NHS service evaluations, and a wide range of scientific and commercial projects across the pharmaceutical product lifecycle. He works closely with clients to deliver robust evidence that supports regulatory, clinical, and strategic objectives.
Caroline O’Leary
Senior Principal, Head of UKI & Nordics Real World Evidence
Timothy Futter
Principal, Head of UKI Real World Primary Data Collection Studies
Rachel Armstrong
Principal, Head of UKI Real World Database Studies
Stephen Benson
Associate Principal, Oncology & Precision Medicine
Sarah Jenner
Principal, Payer, Provider and Government
Rory O’Brien
Principal and subject matter expert for Post Authorisation Safety Studies (PASS)

Related Solution